Synthesis and antimicrobial activity of N'-heteroarylidene-1- adamantylcarbohydrazides and (±)-2-(1-adamantyl)-4-acetyl-5-[5-(4- substituted phenyl-3-isoxazolyl)]-1,3,4-oxadiazolines

Molecules

Volumn 17, Issue 3, 2012, Pages 3475-3483

  El Emam, Ali A ^a   Alrashood, Khalid A ^a   Al Omar, Mohamed A ^a   Al Tamimi, Abdul Malek S ^a  

^a KING SAUD UNIVERSITY   (Saudi Arabia)

Author keywords

1,3,4 oxadiazoles; Adamantane derivatives; Antimicrobial activity; Isoxazoles

Indexed keywords

ANTIINFECTIVE AGENT; CARBOHYDRAZIDE; HYDRAZINE DERIVATIVE; ISOXAZOLE DERIVATIVE; OXADIAZOLE DERIVATIVE;

ARTICLE; CANDIDA ALBICANS; CHEMISTRY; DRUG EFFECT; GRAM POSITIVE BACTERIUM; MICROBIOLOGICAL EXAMINATION; SYNTHESIS;

ANTI-INFECTIVE AGENTS; CANDIDA ALBICANS; GRAM-POSITIVE BACTERIA; HYDRAZINES; ISOXAZOLES; MICROBIAL SENSITIVITY TESTS; OXADIAZOLES;

EID: 84858984031     PISSN: None     EISSN: 14203049     Source Type: Journal    
DOI: 10.3390/molecules17033475     Document Type: Article

References (31)

1. Lamoureux, G.; Artavia, G. Use of the adamantane structure in medicinal chemistry. Curr. Med. Chem. 2010, 17, 2967-2978.
2. Liu, J.; Obando, D.; Liao, V.; Lifa, T.; Codd, R. The many faces of the adamantyl group in drug design. Eur. J. Med. Chem. 2011, 46, 1949-1963.
3. Davies, W. L.; Grunnert, R. R.; Haff, R. F.; McGahen, J. W.; Neumeyer, E. M.; Paulshock, M.; Watts, J. C.; Wood, T. R.; Hermann, E. C.; Hoffmann, C. E. Antiviral activity of 1-adamantamine (amantadine). Science 1964, 144, 862-863.
4. Vernier, V. G.; Harmon, J. B.; Stump, J. M.; Lynes, T. L.; Marvel, M. P.; Smith, D. H. The toxicologic and pharmacologic properties of amantadine hydrochloride. Toxicol. Appl. Pharmacol. 1969, 15, 642-665.
5. Togo, Y.; Hornick, R. B.; Dawkins, A. T. Studies on induced influenza in man. I. Double blind studies designed to assess prophylactic efficacy of amantadine hydrochloride against A2/Rockville/1/65 strain. J. Am. Med. Assoc. 1968, 203, 1089-1094.
6. Zoidis, G.; Kolocouris, N.; Naesens, E.; De Clercq, E. Design and synthesis of 1, 2-annulated adamantane piperidines with anti-influenza virus activity. Bioorg. Med. Chem. 2009, 17, 1534-1541.
7. Van Derpoorten, K.; Balzarini, J.; De Clercq, E.; Poupaert, J. H. Anti-HIV activity of N-1-adamantyl-4-aminophthalimide. Biomed. Pharmacother. 1997, 51, 464-468. (Pubitemid 28088055)
8. El-Emam, A. A.; Al-Deeb, O. A.; Al-Omar, M. A.; Lehmann, J. Synthesis, antimicrobial, and anti-HIV-1 activity of certain 5-(1-adamantyl)-2-substituted thio-1, 3, 4-oxadiazoles and 5-(1-adamantyl)-3-substituted aminomethyl-1, 3, 4-oxadiazoline-2-thiones. Bioorg. Med. Chem. 2004, 12, 5107-5113.
9. Balzarini, J.; Orzeszko, B.; Mauri, J. K.; Orzeszko, A. Synthesis and anti-HIV studies of 2-adamantyl-substituted thiazolidin-4-ones. Eur. J. Med. Chem. 2007, 42, 993-1003. (Pubitemid 46907342)
10. 2 activity as potential anxiolytic and antidepressant agents. J. Med. Chem. 1999, 42, 5077-5094. (Pubitemid 30020259)
11. Owen, J. C. E.; Whitton, P. S. Effect of amantadine and budipune on antidepressant drug-evoked changes in extracellular dopamine in the frontal cortex of freely moving rats. Brain Res. 2006, 1117, 206-212. (Pubitemid 44592584)
12. Omar, K.; Geronikaki, A.; Zoumpoulakis, P.; Camoutsis, C; Soković, M.; Ćirić, A.; Glamoćlija, J. Novel 4-thiazolidinone derivatives as potential antifungal and antibacterial drugs. Bioorg. Med. Chem. 2010, 18, 426-432.
13. Orzeszko, A.; Kamihska, B.; Starościak, B. J. Synthesis and antimicrobial activity of new adamantane derivatives III. Il Farmaco 2002, 57, 619-624. (Pubitemid 34876987)
14. Al-Deeb, O. A.; Al-Omar, M. A.; El-Brollosy, N. R.; Habib, E. E.; Ibrahim, T. M.; El-Emam, A. A. Synthesis, antimicrobial, and anti-inflammatory activities of novel 2-[3-(1-adamantyl)-4-substituted-5-thioxo-1, 2, 4-triazolin-1-yl]acetic acids, 2-[3-(1-adamantyl)-4-substituted-5-thioxo-1, 2, 4-triazolin-1-yl]propionic acids and related derivatives. Arzneim.-Forsch./Drug Res. 2006, 56, 40-47. (Pubitemid 43153767)
15. Kadi, A. A.; El-Brollosy, N. R.; Al-Deeb, O. A.; Habib, E. E.; Ibrahim, T. M.; El-Emam, A. A. Synthesis, antimicrobial, and anti-inflammatory activities of novel 2-(1-adamantyl)-5-substituted-1, 3, 4-oxadiazoles and 2-(1-adamantylamino)-5-substituted-1, 3, 4-thiadiazoles. Eur. J. Med. Chem. 2007, 42, 235-242.
16. Al-Omar, M. A.; Al-Abdullah, E. S.; Shehata, I. A.; Habib, E. E.; Ibrahim, T. M.; El-Emam, A. A. Synthesis, antimicrobial, and anti-inflammatory activities of novel 5-(1-adamantyl)-4-arylideneamino-3-mercapto-1, 2, 4-triazoles and related derivatives. Molecules 2010, 15, 2526-2550.
17. Mamolo, M. G.; Zampieri, D.; Vio, L.; Fermeglia, M.; Ferrone, M.; Pricl, S.; Scialino, G; Banfi, E. Antimycobacterial activity of new 3-substituted 5-(pyridin-4-yl)-3H-1, 3, 4-oxadiazol-2-one and 2-thione derivatives. Preliminary molecular modeling investigations. Bioorg. Med. Chem. 2005, 13, 3797-3809. (Pubitemid 40615930)
18. Macaev, F.; Rusu, G; Bogrebnoi, S.; Gudima, A.; Stingaci, E.; Vlad, L.; Shvets, N; Kandemirli, F.; Dimoglo, A.; Reynolds, R. Synthesis of novel 5-aryl-2-thio-1, 3, 4-oxadiazoles and the study of their structure-anti- mycobacterial activities. Bioorg Med. Chem. 2005, 13, 4842-4850. (Pubitemid 40943508)
19. Andrzejak, V.; Muccioli, G. G; Body-Malapel, M.; El Bakali, J.; Djouina, M.; Renault, N.; Chavatte, P.; Desreumaux, P.; Lambert, D. M.; Millet, R. New FAAH inhibitors based on 3-carboxamido-5-aryl-isoxazole scaffold that protect against experimental colitis. Bioorg Med. Chem. 2011, 19, 3777-3786.
20. Changtam, C; Hongmanee, P.; Suksamrarn, A. Isoxazole analogs of curcuminoids with highly potent multidrug-resistant antimycobacterial activity. Eur. J. Med. Chem. 2010, 45, 4446-4457.
21. El-Emam, A. A.; Ibrahim, T. M. Synthesis, anti-inflammatory and analgesic activity of certain 3-(1-adamantyl)-4-substituted-5-mercapto-1, 2, 4-triazole derivatives. Arzneim.-Forsch./Drug Res. 1991, 41, 1260-1264.
22. Kadi, A. A.; Al-Abdullah, E. S.; Shehata, I. A.; Habib, E. E.; Ibrahim, T. M.; El-Emam, A. A. Synthesis, antimicrobial and anti-inflammatory activities of novel 5-(1-adamantyl)-1, 3, 4-thiadiazole derivatives. Eur. J. Med. Chem. 2010, 45, 5006-5011.
23. Al-Abdullah, E. S.; Shehata, I. A.; Al-Deeb, O. A.; El-Emam, A. A. Microwave-assisted dehydrosulphurization: An efficient, solvent-free synthesis of 5-(1-adamantyl)-2-arylamino-1, 2, 4-triazolo[3, 4-b][1, 3, 4]thiadiazoles. Heterocycles 2007, 71, 379-388.
24. Ficarra, R.; Ficarra, P.; Tommasini, A.; Fenech, G.; Pizzimenti, F. C.; Bisignano, G. 1-Adamantanecarboxylic acid hydrazides with presumed antimicrobial activity. Boll. Chim. Farmaceutico 1984, 123, 317-321. (Pubitemid 14022336)
25. Hassan, G. S.; El-Emam, A. A.; Gad, L. M.; Barghash, A. M. Synthesis, antimicrobial and antiviral testing of some new 1-adamantyl analogues. Saudi Pharm. J. 2010, 18, 123-128.
26. Ishii, M.; Jorge, S. D.; de Oliveira, A. A.; Palace-Berl, F.; Sonehara, I. Y.; Pasqualoto, K. F. M.; Tavares, L. C. Synthesis, molecular modeling and preliminary biological evaluation of a set of 3-acetyl-2, 5-disubstituted-2, 3-dihydro-1, 3, 4-oxadiazole as potential antibacterial, anti-Trypanosoma cruzi and antifungal agents. Bioorg. Med. Chem. 2011, 19, 6292-6301.
27. Hamdi, H.; Passarelli, V.; Romerosa, A. Synthesis, spectroscopy and electrochemistry of new 4-(4-acetyl-5-substituted-4, 5-dihydro-1, 3, 4-oxodiazol-2-yl) methoxy)-2H-chromen-2-ones as a novel class of potential antibacterial and antioxidant derivatives. Compt. Rend. Chim. 2011, 14, 548-555.
28. Joshi, S. D.; Vagdevi, H. M.; Vaidya, V. P.; Gadaginamath, G. S. Synthesis of new 4-pyrrol-1-yl benzoic acid hydrazide analogs and some derived oxadiazole, triazole and pyrrole ring systems: A novel class of potential antibacterial and antitubercular agents. Eur. J. Med. Chem. 2008, 43, 1989-1996.
29. Al-Tamimi, A.-M. S.; Bari, A.; Al-Omar, M. A.; El-Emam, A. A.; Ng, S. W. N'-[(2-n-Butyl-4-chloro-1H-imidazol-5-yl) methylidene]adamantane-1- carbohydrazide sesquihydrate ethanol hemisolvate. Acta Cryst. 2010, E66, o2131.
30. Murray, P. R.; Baron, E. J.; Pfaller, M. A.; Tenover, F. C.; Yolken, R. H. Manual of Clinical Microbiology; Wood, G. L., Washington, J. A., Eds.; American Society for Microbiology: Washington, DC, USA, 1995.
31. National Committee for Clinical Laboratory Standards (NCCLS). Approved standard document M7A; NCCLS: Villanova, PA, USA, 1985.